{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "20205598", "DateCompleted": {"Year": "2010", "Month": "06", "Day": "14"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": ["10.3109/01902140903131200"], "ArticleDate": [], "Journal": {"ISSN": "1521-0499", "JournalIssue": {"Volume": "36", "Issue": "2", "PubDate": {"Year": "2010", "Month": "Mar"}}, "Title": "Experimental lung research", "ISOAbbreviation": "Exp Lung Res"}, "ArticleTitle": "Inhibition of myristoylated alanine-rich C kinase substrate (MARCKS) protein inhibits ozone-induced airway neutrophilia and inflammation.", "Pagination": {"StartPage": "75", "EndPage": "84", "MedlinePgn": "75-84"}, "Abstract": {"AbstractText": ["Evidence suggests inhibition of leukocyte trafficking mitigates, in part, ozone-induced inflammation. In the present study, the authors postulated that inhibition of myristoylated alanine-rich C kinase substrate (MARCKS), an 82-kDa protein with multiple biological roles, could inhibit ozone-induced leukocyte trafficking and cytokine secretions. BALB/c mice (n = 5/cohort) were exposed to ozone (100 ppb) or forced air (FA) for 4 hours. MARCKS-inhibiting peptides, MANS, BIO-11000, BIO-11006, or scrambled control peptide RNS, were intratracheally administered prior to ozone exposure. Ozone selectively enhanced bronchoalveolar lavage (BAL) levels of killer cells (KCs; 6 +/- 0.9-fold), interleukin-6 (IL-6; 12.7 +/- 1.9-fold), and tumor necrosis factor (TNF; 2.1 +/- 0.5-fold) as compared to cohorts exposed to FA. Additionally, ozone increased BAL neutrophils by 21% +/- 2% with no significant (P > .05) changes in other cell types. MANS, BIO-11000, and BIO-11006 significantly reduced ozone-induced KC secretion by 66% +/- 14%, 47% +/- 15%, and 71.1% +/- 14%, and IL-6 secretion by 69% +/- 12%, 40% +/- 7%, and 86.1% +/- 11%, respectively. Ozone-mediated increases in BAL neutrophils were reduced by MANS (86% +/- 7%) and BIO-11006 (84% +/- 2.5%), but not BIO-11000. These studies identify for the first time the novel potential of MARCKS protein inhibitors in abrogating ozone-induced increases in neutrophils, cytokines, and chemokines in BAL fluid. BIO-11006 is being developed as a treatment for chronic obstructive pulmonary disorder (COPD) and is currently being evaluated in a phase 2 clinical study."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Airways Biology Initiative, Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania, 125 South 31st Street, Philadelphia, PA 19104-3403, USA."}], "Identifier": [], "LastName": "Damera", "ForeName": "Gautam", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jester", "ForeName": "William F", "Initials": "WF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jiang", "ForeName": "Meiqi", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhao", "ForeName": "Hengjiang", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fogle", "ForeName": "Homer W", "Initials": "HW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mittelman", "ForeName": "Michael", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Haczku", "ForeName": "Angela", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Murphy", "ForeName": "Edwin", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Parikh", "ForeName": "Indu", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Panettieri", "ForeName": "Reynold A", "Initials": "RA", "Suffix": "Jr"}], "GrantList": [{"GrantID": "RC1 ES018505", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL080676", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "P30 ES013508", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "ES013508", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R44 HL073591", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Exp Lung Res", "NlmUniqueID": "8004944", "ISSNLinking": "0190-2148"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Intracellular Signaling Peptides and Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Marcks protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Peptides"}, {"RegistryNumber": "125267-21-2", "NameOfSubstance": "Myristoylated Alanine-Rich C Kinase Substrate"}], "CommentsCorrectionsList": [{"RefSource": "Exp Lung Res. 2010 Jun;36(5):321"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemically induced", "drug therapy", "immunology"], "DescriptorName": "Bronchitis"}, {"QualifierName": ["cytology", "immunology"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Intracellular Signaling Peptides and Proteins"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Membrane Proteins"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Myristoylated Alanine-Rich C Kinase Substrate"}, {"QualifierName": ["drug effects"], "DescriptorName": "Neutrophil Infiltration"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Peptides"}], "CoiStatement": "<b><i>Declaration of interest:</i></b> The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Koren HS, Devlin RB, Graham DE, Mann R, McGee MP, Horstman DH, Kozumbo WJ, Becker S, House DE, Mc-Donnell WF, et al. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis. 1989;139:407\u2013415.", "ArticleIdList": ["2913889"]}, {"Citation": "Devlin RB, McKinnon KP, Noah T, Becker S, Koren HS. Ozone-induced release of cytokines and fibronectin by alveolar macrophages and airway epithelial cells. Am J Physiol. 1994;266:L612\u2013L619.", "ArticleIdList": ["8023949"]}, {"Citation": "Damera G, Zhao H, Wang M, Smith M, Kirby C, Jester WF, Lawson JA, Panettieri RA., Jr Ozone modulates IL-6 secretion in human airway epithelial and smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2009;296:L674\u2013L683.", "ArticleIdList": ["PMC3286236", "19201813"]}, {"Citation": "Fabbri LM, Aizawa H, Alpert SE, Walters EH, O\u2019Byrne PM, Gold BD, Nadel JA, Holtzman MJ. Airway hyperresponsiveness and changes in cell counts in bronchoalveolar lavage after ozone exposure in dogs. Am Rev Respir Dis. 1984;129:288\u2013291.", "ArticleIdList": ["6696327"]}, {"Citation": "Bhalla DK, Reinhart PG, Bai C, Gupta SK. Amelioration of ozone-induced lung injury by anti-tumor necrosis factor-alpha. Toxicol Sci. 2002;69:400\u2013408.", "ArticleIdList": ["12377989"]}, {"Citation": "Park SJ, Wiekowski MT, Lira SA, Mehrad B. Neutrophils regulate airway responses in a model of fungal allergic airways disease. J Immunol. 2006;176:2538\u20132545.", "ArticleIdList": ["16456015"]}, {"Citation": "Arbuzova A, Schmitz AA, Vergeres G. Cross-talk unfolded: MARCKS proteins. Biochem J. 2002;362:1\u201312.", "ArticleIdList": ["PMC1222354", "11829734"]}, {"Citation": "Blackshear PJ. The MARCKS family of cellular protein kinase C substrates. J Biol Chem. 1993;268:1501\u20131504.", "ArticleIdList": ["8420923"]}, {"Citation": "Aderem AA, Albert KA, Keum MM, Wang JK, Greengard P, Cohn ZA. Stimulus-dependent myristoylation of a major substrate for protein kinase C. Nature. 1988;332:362\u2013364.", "ArticleIdList": ["3352735"]}, {"Citation": "Aderem A. The MARCKS brothers: a family of protein kinase C substrates. Cell. 1992;71:713\u2013716.", "ArticleIdList": ["1423627"]}, {"Citation": "Matsubara M, Titani K, Taniguchi H, Hayashi N. Direct involvement of protein myristoylation in myristoylated alanine-rich C kinase substrate (MARCKS)-calmodulin interaction. J Biol Chem. 2003;278:48898\u201348902.", "ArticleIdList": ["14506265"]}, {"Citation": "Agrawal A, Rengarajan S, Adler KB, Ram A, Ghosh B, Fahim M, Dickey BF. Inhibition of mucin secretion with MARCKS-related peptide improves airway obstruction in a mouse model of asthma. J Appl Physiol. 2007;102:399\u2013405.", "ArticleIdList": ["16946028"]}, {"Citation": "Takashi S, Park J, Fang S, Koyama S, Parikh I, Adler KB. A peptide against the N-terminus of myristoylated alanine-rich C kinase substrate inhibits degranulation of human leukocytes in vitro. Am J Respir Cell Mol Biol. 2006;34:647\u2013652.", "ArticleIdList": ["PMC2644225", "16543603"]}, {"Citation": "Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev. 2006;86:245\u2013278.", "ArticleIdList": ["16371599"]}, {"Citation": "Singer M, Martin LD, Vargaftig BB, Park J, Gruber AD, Li Y, Adler KB. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat Med. 2004;10:193\u2013196.", "ArticleIdList": ["14716307"]}, {"Citation": "Li Y, Martin LD, Spizz G, Adler KB. MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro. J Biol Chem. 2001;276:40982\u201340990.", "ArticleIdList": ["11533058"]}, {"Citation": "Kierstein S, Krytska K, Sharma S, Amrani Y, Salmon M, Panettieri RA, Jr, Zangrilli J, Haczku A. Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice. Allergy. 2008;63:438\u2013446.", "ArticleIdList": ["18315731"]}, {"Citation": "Myou S, Leff AR, Myo S, Boetticher E, Tong J, Meliton AY, Liu J, Munoz NM, Zhu X. Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J Exp Med. 2003;198:1573\u20131582.", "ArticleIdList": ["PMC2194122", "14623911"]}, {"Citation": "Leikauf GD, Driscoll KE, Wey HE. Ozone-induced augmentation of eicosanoid metabolism in epithelial cells from bovine trachea. Am Rev Respir Dis. 1988;137:435\u2013442.", "ArticleIdList": ["3341632"]}, {"Citation": "Leikauf GD, Simpson LG, Santrock J, Zhao Q, Abbinante-Nissen J, Zhou S, Driscoll KE. Airway epithelial cell responses to ozone injury. Environ Health Perspect. 1995;103(Suppl 2):91\u201395.", "ArticleIdList": ["PMC1518831", "7614953"]}, {"Citation": "Hyde DM, Hubbard WC, Wong V, Wu R, Pinkerton K, Plopper CG. Ozone-induced acute tracheobronchial epithelial injury: relationship to granulocyte emigration in the lung. Am J Respir Cell Mol Biol. 1992;6:481\u2013497.", "ArticleIdList": ["1581072"]}, {"Citation": "Kleeberger SR, Hudak BB. Acute ozone-induced change in airway permeability: role of infiltrating leukocytes. J Appl Physiol. 1992;72:670\u2013676.", "ArticleIdList": ["1559947"]}, {"Citation": "Tosi MF, Hamedani A, Brosovich J, Alpert SE. ICAM-1-independent, CD18-dependent adhesion between neutrophils and human airway epithelial cells exposed in vitro to ozone. J Immunol. 1994;152:1935\u20131942.", "ArticleIdList": ["7907108"]}, {"Citation": "Schultheis AH, Bassett DJ. Inflammatory cell influx into ozone-exposed guinea pig lung interstitial and airways spaces. Agents Actions. 1991;34:270\u2013273.", "ArticleIdList": ["1665299"]}, {"Citation": "Cheek JM, McDonald RJ, Rapalyea L, Tarkington BK, Hyde DM. Neutrophils enhance removal of ozone-injured alveolar epithelial cells in vitro. Am J Physiol. 1995;269:L527\u2013L535.", "ArticleIdList": ["7485526"]}, {"Citation": "Williams AS, Issa R, Leung SY, Nath P, Ferguson GD, Bennett BL, Adcock IM, Chung KF. Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-Jun NH2 terminal kinase inhibitor SP600125. J Pharmacol Exp Ther. 2007;322:351\u2013359.", "ArticleIdList": ["17460151"]}, {"Citation": "Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation. 2005;111:97\u2013105.", "ArticleIdList": ["15611372"]}, {"Citation": "Bosson J, Pourazar J, Forsberg B, Adelroth E, Sandstrom T, Blomberg A. Ozone enhances the airway inflammation initiated by diesel exhaust. Respir Med. 2007;101:1140\u20131146.", "ArticleIdList": ["17196810"]}, {"Citation": "Zhao Q, Simpson LG, Driscoll KE, Leikauf GD. Chemokine regulation of ozone-induced neutrophil and monocyte inflammation. Am J Physiol. 1998;274:L39\u2013L46.", "ArticleIdList": ["9458799"]}, {"Citation": "Arjomandi M, Witten A, Abbritti E, Reintjes K, Schmidlin I, Zhai W, Solomon C, Balmes J. Repeated exposure to ozone increases alveolar macrophage recruitment into asthmatic airways. Am J Respir Crit Care Med. 2005;172:427\u2013432.", "ArticleIdList": ["PMC2718526", "15937293"]}, {"Citation": "Driscoll KE, Vollmuth TA, Schlesinger RB. Acute and subchronic ozone inhalation in the rabbit: response of alveolar macrophages. J Toxicol Environ Health. 1987;21:27\u201343.", "ArticleIdList": ["3573074"]}, {"Citation": "Pino MV, Levin JR, Stovall MY, Hyde DM. Pulmonary inflammation and epithelial injury in response to acute ozone exposure in the rat. Toxicol Appl Pharmacol. 1992;112:64\u201372.", "ArticleIdList": ["1733049"]}, {"Citation": "Hotchkiss JA, Harkema JR, Kirkpatrick DT, Henderson RF. Response of rat alveolar macrophages to ozone: quantitative assessment of population size, morphology, and proliferation following acute exposure. Exp Lung Res. 1989;15:1\u201316.", "ArticleIdList": ["2917543"]}, {"Citation": "Bassett D, Elbon-Copp C, Otterbein S, Barraclough-Mitchell H, Delorme M, Yang H. Inflammatory cell availability affects ozone-induced lung damage. J Toxicol Environ Health A. 2001;64:547\u2013565.", "ArticleIdList": ["11760153"]}, {"Citation": "Cho HY, Zhang LY, Kleeberger SR. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. Am J Physiol Lung Cell Mol Physiol. 2001;280:L537\u2013L546.", "ArticleIdList": ["11159038"]}, {"Citation": "Park JW, Taube C, Joetham A, Takeda K, Kodama T, Dakhama A, McConville G, Allen CB, Sfyroera G, Shultz LD, Lambris JD, Giclas PC, Holers VM, Gelfand EW. Complement activation is critical to airway hyperresponsiveness after acute ozone exposure. Am J Respir Crit Care Med. 2004;169:726\u2013732.", "ArticleIdList": ["14701711"]}, {"Citation": "Michalec L, Choudhury BK, Postlethwait E, Wild JS, Alam R, Lett-Brown M, Sur S. CCL7 and CXCL10 orchestrate oxidative stress-induced neutrophilic lung inflammation. J Immunol. 2002;168:846\u2013852.", "ArticleIdList": ["11777981"]}, {"Citation": "Criqui GI, Solomon C, Welch BS, Ferrando RE, Boushey HA, Balmes JR. Effects of azithromycin on ozone-induced airway neutrophilia and cytokine release. Eur Respir J. 2000;15:856\u2013862.", "ArticleIdList": ["10853849"]}, {"Citation": "Jones SL, Eckert RE, Adler KB. MARCKS protein regulation of human neutrophil migration in vitro. FASEB J. 2008;22:666.6.", "ArticleIdList": ["PMC2874444", "19574534"]}, {"Citation": "Nairn AC, Aderem A. Calmodulin and protein kinase C crosstalk: the MARCKS protein is an actin filament and plasma membrane cross-linking protein regulated by protein kinase C phosphorylation and by calmodulin. Ciba Found Symp. 1992;164:145\u2013154. discussion 154\u2013161.", "ArticleIdList": ["1395931"]}, {"Citation": "Park HS, Jung KS, Hwang SC, Nahm DH, Yim HE. Neutrophil infiltration and release of IL-8 in airway mucosa from subjects with grain dust-induced occupational asthma. Clin Exp Allergy. 1998;28:724\u2013730.", "ArticleIdList": ["9677137"]}, {"Citation": "Altstaedt J, Kirchner H, Rink L. Cytokine production of neutrophils is limited to interleukin-8. Immunology. 1996;89:563\u2013568.", "ArticleIdList": ["PMC1456568", "9014822"]}, {"Citation": "Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22:672\u2013688.", "ArticleIdList": ["14582923"]}, {"Citation": "Kehrl HR, Peden DB, Ball B, Folinsbee LJ, Horstman D. Increased specific airway reactivity of persons with mild allergic asthma after 7.6 hours of exposure to 0.16 ppm ozone. J Allergy Clin Immunol. 1999;104:1198\u20131204.", "ArticleIdList": ["10589001"]}, {"Citation": "Wagner JG, Jiang Q, Harkema JR, Illek B, Patel DD, Ames BN, Peden DB. Ozone enhancement of lower airway allergic inflammation is prevented by gamma-tocopherol. Free Radic Biol Med. 2007;43:1176\u20131188.", "ArticleIdList": ["PMC4465777", "17854713"]}, {"Citation": "Wagner JG, Hotchkiss JA, Harkema JR. Enhancement of nasal inflammatory and epithelial responses after ozone and allergen coexposure in Brown Norway rats. Toxicol Sci. 2002;67:284\u2013294.", "ArticleIdList": ["12011488"]}]}], "History": [{"Year": "2010", "Month": "3", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "3", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2014", "Month": "6", "Day": "20"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20205598", "NIHMS590502", "PMC4064305", "10.3109/01902140903131200"]}}], "PubmedBookArticle": []}